I second this! CBIS has such a huge advantage over the other players. Plus there really aren't any other players with CBIS' profile of R&D of cannabinoids and patient treatment, most of the other pot players at this point are pushing various products or technologies for growers and users.
News 
Market Data 
Discover 
